XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - EUR (€)
€ in Millions
Jun. 30, 2023
Dec. 31, 2022
Assets    
Property, plant and equipment owned € 9,804 € 9,869
Right-of-use assets 1,723 1,815
Goodwill 49,243 49,892
Other intangible assets 24,590 21,640
Investments accounted for using the equity method 538 677
Other non-current assets 2,992 3,095
Non-current income tax assets 240 242
Deferred tax assets 5,980 5,381
Non-current assets 95,110 92,611
Inventories 9,970 8,960
Accounts receivable 8,289 8,424
Other current assets 3,371 3,532
Current income tax assets 353 374
Cash and cash equivalents 7,993 12,736
Current assets 29,976 34,026
Assets held for sale or exchange 267 85
TOTAL ASSETS 125,353 126,722
Equity and liabilities    
Equity attributable to equity holders of Sanofi 72,629 74,784
Equity attributable to non-controlling interests 318 368
Total equity 72,947 75,152
Long-term debt 14,241 14,857
Non-current lease liabilities 1,839 1,904
Non-current liabilities related to business combinations and to non-controlling interests 563 674
Non-current provisions and other non-current liabilities 7,088 6,341
Non-current income tax liabilities 1,928 1,979
Deferred tax liabilities 1,950 1,841
Non-current liabilities 27,609 27,596
Accounts payable 7,365 6,813
Current liabilities related to business combinations and to non-controlling interests 154 105
Current provisions and other current liabilities 11,917 12,021
Current income tax liabilities 377 574
Current lease liabilities 253 277
Short-term debt and current portion of long-term debt 4,694 4,174
Current liabilities 24,760 23,964
Liabilities related to assets held for sale or exchange 37 10
TOTAL EQUITY AND LIABILITIES € 125,353 € 126,722